Filing Details
- Accession Number:
- 0001209191-14-012246
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-20 15:00:26
- Reporting Period:
- 2014-02-18
- Filing Date:
- 2014-02-20
- Accepted Time:
- 2014-02-20 15:00:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597789 | Rafael Tordjman | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-18 | 1,614,382 | $0.00 | 1,614,382 | No | 4 | C | Indirect | By Sofinnova Capital VI FCPR |
| Common Stock | Acquisiton | 2014-02-18 | 260,340 | $0.00 | 1,874,722 | No | 4 | C | Indirect | By Sofinnova Capital VI FCPR |
| Common Stock | Acquisiton | 2014-02-18 | 230,769 | $13.00 | 2,105,491 | No | 4 | P | Indirect | By Sofinnova Capital VI FCPR |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Sofinnova Capital VI FCPR |
| No | 4 | C | Indirect | By Sofinnova Capital VI FCPR |
| No | 4 | P | Indirect | By Sofinnova Capital VI FCPR |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-02-18 | 13,124,932 | $0.00 | 1,614,382 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-02-18 | 2,116,562 | $0.00 | 260,340 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Every 8.13 shares of Series A Preferred Stock automatically converted into 1 share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- Shares held by Sofinnova Capital VI FCPR. The Reporting Person shares voting and investment power with respect to the shares held by Sofinnova Capital VI FCPR and disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein.
- Every 8.13 shares of Series B Preferred Stock automatically converted into 1 share of Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- The shares were purchased at the Issuer's initial public offering.
Billionaire Hedge Funds
